AWH stock icon

Aspira Women's Health

0.8100 USD
-0.0200
2.41%
At close Dec 4, 4:00 PM EST
After hours
0.8194
+0.0094
1.16%
1 day
-2.41%
5 days
6.69%
1 month
-8.58%
3 months
-18.67%
6 months
-62.15%
Year to date
-80.62%
1 year
-75.08%
5 years
-98.70%
10 years
-99.86%
 

About: Aspira Womens Health Inc is engaged in developing and commercializing diagnostic tests for gynecologic diseases. Its products include OvaSuite which is a portfolio of blood tests that applies proprietary algorithms incorporating patient features; OvaWatch intended for use in assessing the risk of ovarian cancer for women with adnexal masses; and Ova1Plus is a portfolio of blood tests, Ova1Plus is a combination of two FDA-cleared tests for women with pelvic masses who are planned for surgery.

Employees: 64

0
Funds holding %
of 6,790 funds
Analysts bullish %

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

1.46% more ownership

Funds ownership: 11.23% [Q2] → 12.69% (+1.46%) [Q3]

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

12% less funds holding

Funds holding: 26 [Q2] → 23 (-3) [Q3]

21% less capital invested

Capital invested by funds: $2.08M [Q2] → $1.64M (-$442K) [Q3]

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Research analyst outlook

We haven’t received any recent analyst ratings for AWH.

Financial journalist opinion

Based on 3 articles about AWH published over the past 30 days

Neutral
GlobeNewsWire
2 days ago
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award
The Company received the first $2 million from the ARPA-H Sprint for Women's Health Award The Company received the first $2 million from the ARPA-H Sprint for Women's Health Award
Aspira Women's Health Successfully Reaches the First Milestone of the ARPA-H $10 Million Award
Negative
Zacks Investment Research
2 weeks ago
Aspira (AWH) Reports Q3 Loss, Lags Revenue Estimates
Aspira (AWH) came out with a quarterly loss of $0.23 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to loss of $0.48 per share a year ago.
Aspira (AWH) Reports Q3 Loss, Lags Revenue Estimates
Neutral
Seeking Alpha
2 weeks ago
Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call Transcript
Aspira Women's Health Inc. (NASDAQ:AWH ) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Nicole Sandford - Chief Executive Officer & Director Sandy Milligan - President John Kallassy - Interim Chief Financial Officer Conference Call Participants Operator Good morning, ladies and gentlemen and welcome to Aspira Women's Health Incorporated Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Aspira Women's Health Inc. (AWH) Q3 2024 Earnings Call Transcript
Neutral
GlobeNewsWire
1 month ago
Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024
Management to Announce Earnings Results and hold a call at 8:30 am ET Management to Announce Earnings Results and hold a call at 8:30 am ET
Aspira Women's Health to Announce Third Quarter Earnings Results and Host a Conference Call on Thursday, November 14, 2024
Neutral
GlobeNewsWire
1 month ago
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024
Event to feature presentations from Dr. Kevin Elias, Dr. Richard Gersh, Dr. Sandra Milligan, and Dr. Todd Pappas on the Company's development pipeline Event to feature presentations from Dr. Kevin Elias, Dr. Richard Gersh, Dr. Sandra Milligan, and Dr. Todd Pappas on the Company's development pipeline
Aspira Women's Health Issues Letter to Shareholders and Announces Virtual Research & Development Day on October 29, 2024
Neutral
GlobeNewsWire
1 month ago
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health
Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis Aspira aims to develop a multi-marker miRNA blood test to aid in the detection of endometriosis
Aspira Women's Health Selected to Receive $10 Million Award from ARPA-H's Sprint for Women's Health
Neutral
GlobeNewsWire
1 month ago
Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®
New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation (CLEP) approval allows for OvaWatch® to be marketed in New York State New York State Department of Health (NYSDOH) Clinical Laboratory Evaluation (CLEP) approval allows for OvaWatch® to be marketed in New York State
Aspira Women's Health Receives Approval from New York State Department of Health for OvaWatch®
Negative
GuruFocus
1 month ago
AWH Stock Plummets as Financial Data Reflects Losses
Annex Insurance (AWH, Financial) stock recently experienced a sharp decline, dropping 7.47% to $0.761 per share. The trading volume stood at 16,266 shares, with a turnover rate of 0.10% and a price fluctuation of 2.62%.
AWH Stock Plummets as Financial Data Reflects Losses
Negative
GuruFocus
2 months ago
Aspira Womens Health (AWH) Shares Plunge Amid Financial Challenges
Aspira Womens Health (AWH, Financial) experienced a significant stock price drop of 7.80%, reaching $0.775 per share. The trading volume stood at 14,064 shares with a turnover rate of 0.09% and a volatility of 7.47%.
Aspira Womens Health (AWH) Shares Plunge Amid Financial Challenges
Neutral
GlobeNewsWire
2 months ago
Aspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
AUSTIN, Texas, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that Nicole Sandford, CEO of Aspira Women's Health will present at the H.C. Wainwright 26th Annual Global Investment Conference being held September 9-11, 2024 at the Lotte New York Palace Hotel in New York, NY.
Aspira Women's Health to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Charts implemented using Lightweight Charts™